Hikma Ventures Leads Series B Extension In Activ Surgical To Support The Global Commercialization Of Its Platform
Hikma Ventures Leads Series B Extension In Activ Surgical To Support The Global Commercialization Of Its Platform
03/22/22, 9:00 AM
Location
londonRound Type
series b
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced that its venture capital arm, Hikma Ventures has led an $15 million USD round of financing for Activ Surgical, a pioneering digital surgery imaging startup that is developing groundbreaking interoperative surgical intelligence hardware and software. The investment is an extension of the Series B round that was previously announced by Activ Surgical in September 2021. This most recent financing, which also saw participation from existing investors, brings the total Series B round to $60 million USD.
Company Info
Location
london, ontario, canada
Additional Info
Founded in August 2015, Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals. Hikma Ventures invests in global start-ups where Hikma's expertise can accelerate revenue growth and enhance value creation by providing ventures with access to the resources of a multinational pharmaceutical company. For more information, please visit www.hikmaventures.com.